Generic Versions of Boniva Approved
Post-menopausal women with osteoporosis now have three generic alternatives to the prescription drug Boniva , a once-monthly tablet designed to treat or prevent bone loss.
FDA Approves Generic Boniva
The U.S. Food and Drug Administration approved the first generic versions of Boniva ( ibandronate ) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.
Plum Out of Bone Density
The old saying, "an apple a day keeps the doctor away" is certainly sage advice. But apples are having to take a back seat to dried plums in the osteoporosis department.
FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer
The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).
The Truth About Men and Osteoporosis
Osteoporosis, a common bone disease, affects women about 80 percent of the time. This often leads to the mistaken assumption that men aren't affected by the disease.
Vitamin D: Osteoporosis Patients Best Friend
In order to maximize chances of getting a therapeutic response from bisphosphonates, vitamin D levels need to be high.
Dem Bones Gonna Rise Again
It is always nice to report when a drug benefiting one health issue accidentally benefits another! Fosamax, Boniva and Actonel (bisphosphonates), prescribed to increase bone density in osteoporosis patients, appears to extend the lives of patients as well.
Bone Drug Isn't All Bad
According to Australian researchers, taking bisphosphonates (drugs used to improve bone health) may increase the life span of elderly women.